Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-02-23 @ 6:27 AM
Study NCT ID:
NCT00611468
Status:
COMPLETED
Last Update Posted:
2011-08-22
First Post:
2008-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-29
First Submit QC Date:
None
Study First Post Date:
2008-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-07-01
Results First Submit QC Date:
None
Results First Post Date:
2011-07-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-08-18
Last Update Post Date:
2011-08-22
Last Update Post Date Type:
ESTIMATED